Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use
批准号:
10578714
负责人:
Suthat Liangpunsakul
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-10-01 至 2026-06-30
关键词:
AbstinenceAlcohol consumptionAlcoholsAnemiaAwardBiological MarkersCaringCellsClinicalConsumptionCounselingDangerousnessDataDetectionDiabetes MellitusDiagnosisDiagnosticDiseaseDyslipidemiasFunctional disorderFundingGlucoseGoalsHealthHemoglobinHumanIndividualInflammatoryInflammatory ResponseInterventionLaboratoriesLinkLipidsMachine LearningMethodsModelingPathologyPathway interactionsPatient Self-ReportPatientsPerformancePrevalenceProcessProteomicsQuestionnairesRelapseRelative RisksResearchRiskRoleScreening procedureSensitivity and SpecificitySerumStatistical MechanicsSystems BiologyTestingTimeValidationVeteransadverse outcomealcohol measurementalcohol monitoringalcohol rehabilitationalcohol related problemalcohol riskalcohol screeningbiomarker panelbody systemclinical careclinical practicedisease phenotypedrinkingdrinking behaviormonocytenovelpotential biomarkerrelapse patientsresponserisk prediction modelscreeningtranscriptomicstrendvigilance
中文摘要
项目摘要
提高生物标志物识别近期过度饮酒(EAU)的敏感性和特异性,
退伍军人是一个及时的研究目标。EAU被认为是一个新出现的健康相关问题
尤其是从战场上回来的老兵。因此,有必要提高警惕并采取行动
识别和辅导有风险的退伍军人。老年EAU患者的诊断和护理受到以下因素的阻碍:
缺乏具有高诊断性能的测试,可以检测出饮酒或复发的危险水平
在治疗期间。这些测试对于EAU退伍军人的筛查和护理是必不可少的。的
EAU检测不足的后果,因此延迟干预是严重的,因为酒精的相对风险-
相关的健康状况随着每天饮酒的量和持续时间的增加而增加。过度
酒精使用(EAU)正在被认为是一个新出现的健康相关问题,特别是在退伍军人中
从战斗中归来。我们的初步数据使用蛋白质组学和转录组学的新景观,
方法已经揭示了EAU的病理生理学的几个途径;这可能导致
人类的病理学本次CSR&D Merit Review Award申请旨在寻求支持,
生物标志物组的作用;来自EAU对炎症反应的影响,以筛选
EAU和近期饮酒量以及戒酒监测。我们假设
(i)这些源自系统生物学分析的生物标志物是有用的
在临床实践中筛查EAU和近期饮酒量,与
常规标志物和(ii)将这些标志物组合成单一风险模型预测,
机器学习和统计力学将彻底改变我们在临床实践中筛选EAU的方式。到
为了检验这一假设,我们计划追求以下具体目标:具体目标#1:确定
通过系统生物学方法鉴定EAU对器官系统的影响,
作为EAU潜在生物标志物的这些新靶点的相对量,以及具体目标#2:开发
并结合机器学习和统计学方面验证用于预测EAU的风险模型
力学如果成功的话,这个项目的结果将彻底改变退伍军人的筛选方法
过量饮酒
英文摘要
Project Summary
Increasing the sensitivity and specificity of biomarkers for recognizing recent, excessive alcohol use (EAU) in
Veterans is a timely goal of research. EAU is becoming recognized as an emerging health-related problem
especially among veterans returning from combats. As such, there is a need for increased vigilance and action
to identify and counsel at-risk veterans. The diagnosis and care of veteran patients with EAU is hampered by
the lack of tests with high diagnostic performance that can detect dangerous levels of drinking or relapse
during therapy. Such tests would be indispensable for screening and care for veterans with EAU. The
consequences of under-detection of EAU, thus delayed intervention are serious because relative risk of alcohol-
related health conditions is increased with the amounts and duration of alcohol consumed per day. Excessive
alcohol use (EAU) is becoming recognized as an emerging health-related problem especially among veterans
returning from combats. Our preliminary data using the new landscape of proteomic and transcriptomic
approaches have uncovered the pathophysiology of EAU on several pathways; which might lead to
pathology in human. This renewal CSR&D Merit Review Award application seeks the support to define
the roles of the panels of biomarkers; derived from the effect of EAU on inflammatory response to screen
for EAU and quantity of recent alcohol consumption and monitoring for abstinence. We hypothesize that
(i) these biomarkers derived from system biology analyses are useful and have a better diagnostic performance
to screen for EAU and the quantity of recent alcohol consumption in clinical practice, when compared to the
conventional markers and (ii) the combination of these markers into a single risk model prediction using
machine learning and statistical mechanics will revolutionize the way we screen for EAU in clinical practice. To
test this hypothesis, we plan to pursue the following specific aims; SPECIFIC AIM # 1: Determine the effect of
EAU on organ system identified by system biology approach and by detecting, identifying, and comparing the
relative quantity of these novel targets as potential biomarkers for EAU, and SPECIFIC AIM # 2: To develop
and validate of a risk model for prediction of EAU combining aspects of machine learning and statistical
mechanics. If successful, the results from this project will revolutionize the screening methods for veterans
with excessive alcohol use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FKBP5 in the pathogenesis of alcohol-associated liver disease
-
批准号:10501012
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2022
-
负责人:Suthat Liangpunsakul
-
依托单位:
FKBP5 in the pathogenesis of alcohol-associated liver disease
-
批准号:10704686
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2022
-
负责人:Suthat Liangpunsakul
-
依托单位:
S-adenosylmethionine treatment in alcoholic cirrhosis
-
批准号:10022083
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2019
-
负责人:Suthat Liangpunsakul
-
依托单位:
S-adenosylmethionine treatment in alcoholic cirrhosis
-
批准号:10247836
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2019
-
负责人:Suthat Liangpunsakul
-
依托单位:
S-adenosylmethionine treatment in alcoholic cirrhosis
-
批准号:10491274
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2019
-
负责人:Suthat Liangpunsakul
-
依托单位:
Novel animal models to study miRNA-mediated alcoholic liver disease
-
批准号:9794130
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Novel animal models to study miRNA-mediated alcoholic liver disease
-
批准号:10205559
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Novel animal models to study miRNA-mediated alcoholic liver disease
-
批准号:10228102
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis
-
批准号:10190739
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis
-
批准号:10440367
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Novel animal models to study miRNA-mediated alcoholic liver disease
-
批准号:10430148
-
项目类别:
-
资助金额:$37.97万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis
-
批准号:9791142
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2018
-
负责人:Suthat Liangpunsakul
-
依托单位:
Novel biomarkers as a clinical tool for excessive alcohol use screening
-
批准号:9750568
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2016
-
负责人:Suthat Liangpunsakul
-
依托单位:
Long noncoding RNAs in alcoholic liver disease
-
批准号:9110485
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2016
-
负责人:Suthat Liangpunsakul
-
依托单位:
Novel biomarkers as a clinical tool for excessive alcohol use screening
-
批准号:9170557
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2016
-
负责人:Suthat Liangpunsakul
-
依托单位:
Mechanistic-based biomarkers of abusive alcohol consumption
-
批准号:10038798
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Suthat Liangpunsakul
-
依托单位:
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption
-
批准号:8391086
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Suthat Liangpunsakul
-
依托单位:
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption
-
批准号:8590183
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Suthat Liangpunsakul
-
依托单位:
Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use
-
批准号:10260146
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Suthat Liangpunsakul
-
依托单位:
Serum Proteomic Profiles as Biomarkers of Abusive Alcohol Consumption
-
批准号:8140936
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Suthat Liangpunsakul
-
依托单位:
海外基金